王辰，呼吸病学与危重症医学专家。中国工程院院士，美国国家医学科学院、欧洲科学院外籍院士，欧洲科学与艺术学院院士，永利集团3044官网欢迎您学部委员。中国工程院副院长，永利集团3044官网欢迎您院校长，国家呼吸医学中心主任。担任世界卫生组织（WHO）多项重要专业职务。Chinese Medical Journal（中华医学杂志英文版）总编辑。

长期从事呼吸与危重症医学临床、教学与研究工作。主要研究领域包括呼吸病学、群医学及公共卫生。在慢性气道疾病、肺栓塞、呼吸衰竭、新发呼吸道传染病、控制吸烟等领域作出多项重要创新，改善医疗卫生实践。

1. Chen S#*, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, Wang Z, Li W, Geldsetzer P, Bärnighausen T, Bloom DE, Wang C*. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncol. 2023 Apr 1;9(4):465-472. (IF=28.4, ESI)

2.   He Z#, Ren L#, Yang J#, Guo L#, Feng L#, Ma C, Wang X, Leng Z, Tong X, Zhou W, Wang G, Zhang T, Guo Y, Wu C, Wang Q, Liu M, Wang C, Jia M, Hu X, Wang Y, Zhang X, Hu R, Zhong J, Yang J, Dai J, Chen L, Zhou X, Wang J*, Yang W*, Wang C*. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. Lancet. 2021 Mar 20;397(10279):1075-1084. (IF=202.731, C100, ESI)

3.   Wang Y#, Zhang D#, Du G#, Du R#, Zhao J#, Jin Y#, Fu S#, Gao L#, Cheng Z#, Lu Q# , Hu Y#, Luo G#, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B*, Wang C*. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. (IF=79.323, C100, F1000, R, PIII, ESI)

4.   Wang C#*, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020 Feb 15;395(10223):470-473. (IF=79.323, C100)

5.   Huang K#, Yang T#, Xu J#, Yang L#, Zhao J#, Zhang X#, Bai C#, Kang J#, Ran P#, Shen H#, Wen F#, Chen Y#, Sun T#, Shan G#, Lin Y#, Xu G#, Wu S#, Wang C, Wang R, Shi Z, Xu Y, Ye X, Song Y, Wang Q, Zhou Y, Li W, Ding L, Wan C, Yao W, Guo Y, Xiao F, Lu Y, Peng X, Zhang B, Xiao D, Wang Z, Chen Z, Bu X, Zhang H, Zhang X, An L, Zhang S, Zhu J, Cao Z, Zhan Q, Yang Y, Liang L, Tong X, Dai H, Cao B, Wu T, Chung KF, He J, Wang C*; China Pulmonary Health (CPH) Study Group. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019 Aug 3;394(10196):407-418. (IF=60.390, C100, ESI)

6.   Wang C#*, Xu J#, Yang L#, Xu Y#, Zhang X#, Bai C#, Kang J#, Ran P#, Shen H#, Wen F#, Huang K#, Yao W#, Sun T#, Shan G#, Yang T#, Lin Y#, Wu S#, Zhu J#, Wang R, Shi Z, Zhao J, Ye X, Song Y, Wang Q, Zhou Y, Ding L, Yang T, Chen Y, Guo Y, Xiao F, Lu Y, Peng X, Zhang B, Xiao D, Chen CS, Wang Z, Zhang H, Bu X, Zhang X, An L, Zhang S, Cao Z, Zhan Q, Yang Y, Cao B, Dai H, Liang L, He J*; China Pulmonary Health Study Group. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018 Apr 28;391(10131):1706-1717. (IF=59.102, C100, ESI)

7.   Zhan Q#*, Sun B, Liang L, Yan X, Zhang L, Yang J, Wang L, Ma Z, Shi L, Wei L, Li G, Yang L, Shi Z, Chen Y, Xu Q, Li W, Zhu X, Wang Z, Sun Y, Zhuo J, Liu Y, Li X, Wang C*. Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med. 2012 Feb;40(2):455-60. (IF=6.124, C100, F1000)

8.   Wang C#*, Cao B*, Liu QQ, Zou ZQ, Liang ZA, Gu L, Dong JP, Liang LR, Li XW, Hu K, He XS, Sun YH, An Y, Yang T, Cao ZX, Guo YM, Wen XM, Wang YG, Liu YL, Jiang LD. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med. 2011 Aug 16;155(4):217-25. (IF=16.733, C100)

9.   Wang C#*, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; China Venous Thromboembolism (VTE) Study Group. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest. 2010 Feb;137(2):254-62. (IF=6.519, C100, R)

10. Cao B#, Li XW#, Mao Y#, Wang J#, Lu HZ#, Chen YS#, Liang ZA#, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C#*; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009 Dec 24;361(26):2507-17. (IF=47.050, C100, R, ESI)